T

TriSalus Life Sciences Inc
NASDAQ:TLSI

Watchlist Manager
TriSalus Life Sciences Inc
NASDAQ:TLSI
Watchlist
Price: 4.53 USD 2.26% Market Closed
Market Cap: 132.8m USD
Have any thoughts about
TriSalus Life Sciences Inc?
Write Note

Intrinsic Value

TLSI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one TLSI stock under the Base Case scenario is 4.44 USD. Compared to the current market price of 4.53 USD, TriSalus Life Sciences Inc is Overvalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TLSI Intrinsic Value
4.44 USD
Overvaluation 2%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation Backtest
TriSalus Life Sciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for TLSI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about TLSI?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
TriSalus Life Sciences Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about TriSalus Life Sciences Inc

Provide an overview of the primary business activities
of TriSalus Life Sciences Inc.

What unique competitive advantages
does TriSalus Life Sciences Inc hold over its rivals?

What risks and challenges
does TriSalus Life Sciences Inc face in the near future?

Has there been any significant insider trading activity
in TriSalus Life Sciences Inc recently?

Summarize the latest earnings call
of TriSalus Life Sciences Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for TriSalus Life Sciences Inc.

Provide P/S
for TriSalus Life Sciences Inc.

Provide P/E
for TriSalus Life Sciences Inc.

Provide P/OCF
for TriSalus Life Sciences Inc.

Provide P/FCFE
for TriSalus Life Sciences Inc.

Provide P/B
for TriSalus Life Sciences Inc.

Provide EV/S
for TriSalus Life Sciences Inc.

Provide EV/GP
for TriSalus Life Sciences Inc.

Provide EV/EBITDA
for TriSalus Life Sciences Inc.

Provide EV/EBIT
for TriSalus Life Sciences Inc.

Provide EV/OCF
for TriSalus Life Sciences Inc.

Provide EV/FCFF
for TriSalus Life Sciences Inc.

Provide EV/IC
for TriSalus Life Sciences Inc.

Show me price targets
for TriSalus Life Sciences Inc made by professional analysts.

What are the Revenue projections
for TriSalus Life Sciences Inc?

How accurate were the past Revenue estimates
for TriSalus Life Sciences Inc?

What are the Net Income projections
for TriSalus Life Sciences Inc?

How accurate were the past Net Income estimates
for TriSalus Life Sciences Inc?

What are the EPS projections
for TriSalus Life Sciences Inc?

How accurate were the past EPS estimates
for TriSalus Life Sciences Inc?

What are the EBIT projections
for TriSalus Life Sciences Inc?

How accurate were the past EBIT estimates
for TriSalus Life Sciences Inc?

Compare the revenue forecasts
for TriSalus Life Sciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of TriSalus Life Sciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of TriSalus Life Sciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of TriSalus Life Sciences Inc compared to its peers.

Compare the P/E ratios
of TriSalus Life Sciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing TriSalus Life Sciences Inc with its peers.

Analyze the financial leverage
of TriSalus Life Sciences Inc compared to its main competitors.

Show all profitability ratios
for TriSalus Life Sciences Inc.

Provide ROE
for TriSalus Life Sciences Inc.

Provide ROA
for TriSalus Life Sciences Inc.

Provide ROIC
for TriSalus Life Sciences Inc.

Provide ROCE
for TriSalus Life Sciences Inc.

Provide Gross Margin
for TriSalus Life Sciences Inc.

Provide Operating Margin
for TriSalus Life Sciences Inc.

Provide Net Margin
for TriSalus Life Sciences Inc.

Provide FCF Margin
for TriSalus Life Sciences Inc.

Show all solvency ratios
for TriSalus Life Sciences Inc.

Provide D/E Ratio
for TriSalus Life Sciences Inc.

Provide D/A Ratio
for TriSalus Life Sciences Inc.

Provide Interest Coverage Ratio
for TriSalus Life Sciences Inc.

Provide Altman Z-Score Ratio
for TriSalus Life Sciences Inc.

Provide Quick Ratio
for TriSalus Life Sciences Inc.

Provide Current Ratio
for TriSalus Life Sciences Inc.

Provide Cash Ratio
for TriSalus Life Sciences Inc.

What is the historical Revenue growth
over the last 5 years for TriSalus Life Sciences Inc?

What is the historical Net Income growth
over the last 5 years for TriSalus Life Sciences Inc?

What is the current Free Cash Flow
of TriSalus Life Sciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for TriSalus Life Sciences Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
TriSalus Life Sciences Inc

Current Assets 27.9m
Cash & Short-Term Investments 16.5m
Receivables 4.7m
Other Current Assets 6.8m
Non-Current Assets 4.5m
PP&E 3m
Intangibles 1.1m
Other Non-Current Assets 424k
Current Liabilities 12m
Accounts Payable 2m
Accrued Liabilities 9.7m
Other Current Liabilities 328k
Non-Current Liabilities 44.6m
Long-Term Debt 21.3m
Other Non-Current Liabilities 23.3m
Efficiency

Earnings Waterfall
TriSalus Life Sciences Inc

Revenue
24.7m USD
Cost of Revenue
-3.1m USD
Gross Profit
21.7m USD
Operating Expenses
-74.1m USD
Operating Income
-52.5m USD
Other Expenses
-4.8m USD
Net Income
-57.2m USD

Free Cash Flow Analysis
TriSalus Life Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

TLSI Profitability Score
Profitability Due Diligence

TriSalus Life Sciences Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional Revenue Growth Forecast
Exceptional ROE
Positive Gross Profit
47/100
Profitability
Score

TriSalus Life Sciences Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

TLSI Solvency Score
Solvency Due Diligence

TriSalus Life Sciences Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
48/100
Solvency
Score

TriSalus Life Sciences Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TLSI Price Targets Summary
TriSalus Life Sciences Inc

Wall Street analysts forecast TLSI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLSI is 12.16 USD with a low forecast of 10.1 USD and a high forecast of 16.8 USD.

Lowest
Price Target
10.1 USD
123% Upside
Average
Price Target
12.16 USD
168% Upside
Highest
Price Target
16.8 USD
271% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for TLSI?

Click here to dive deeper.

Dividends

TriSalus Life Sciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TLSI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TLSI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

TriSalus Life Sciences Inc

Country

United States of America

Industry

N/A

Market Cap

123m USD

Dividend Yield

0%

Description

TriSalus Life Sciences Inc is a US-based company operating in industry. The company is headquartered in Westminster, Colorado. The company went IPO on 2020-12-18. TriSalus Life Sciences, Inc. is an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors. The Company’s platform includes devices that utilize a drug delivery technology and a clinical-stage investigational immunotherapy. The Company’s two FDA-cleared devices use its Pressure-Enabled Drug Delivery (PEDD) approach to deliver a range of therapeutics: the TriNav Infusion System for hepatic arterial infusion of liver tumors and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. SD-101, the Company’s investigational immunotherapeutic candidate, is designed to improve patient outcomes by treating the immunosuppressive environment. Patient data generated during Pressure-Enabled Regional Immuno-Oncology (PERIO) clinical trials support the hypothesis that SD-101 delivered through PEDD may has favorable immune effects on the liver and systemically.

Contact

COLORADO
Westminster
6272 West 91St Avenue
+14153368917
trisaluslifesci.com

IPO

2020-12-18

Employees

-

Officers

CEO, President & Director
Ms. Mary T. Szela B.S.N., M.B.A.
CFO & Director
Mr. Sean Edward Murphy
Vice President of Operations
Ms. Lori Ann Santamaria
Chief Scientific & Manufacturing Officer
Dr. Bryan F. Cox Ph.D.
Senior VP of Investor Relations & Treasurer
Mr. James E. Young
Senior Vice President of Corporate Development & Strategy
Dr. Richard B. Marshak M.B.A., MBA, VMD
Show More
Chief Regulatory Officer
Ms. Jennifer L. Stevens J.D.
President of Commercial Operations
Ms. Jodi Devlin
Show Less

See Also

Discover More
What is the Intrinsic Value of one TLSI stock?

The intrinsic value of one TLSI stock under the Base Case scenario is 4.44 USD.

Is TLSI stock undervalued or overvalued?

Compared to the current market price of 4.53 USD, TriSalus Life Sciences Inc is Overvalued by 2%.

Back to Top